Key facts
- Notable investors include California Life Sciences, Heartfelt (Private Equity).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Misogi Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Misogi Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Misogi Labs
Developer of an AI-powered drug discovery platform designed to accelerate pharmaceutical research and development by simulating small molecule behavior in virtual human physiology. The company offers physics-based predictive models combined with generative AI-driven multi-agent coordination, guiding medicinal chemists through multi-parameter optimization workflows, enabling pharmaceutical R&D teams to reduce experimental dead ends, make informed decisions, and progress compounds toward clinical development efficiently.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Employees
- 3
- Website
- coincidencelabs.com/
- Ownership
- Privately Held (backing)
Misogi Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Misogi Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Misogi Labs in its N-PORT filings yet. We sweep new filings monthly.